Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy.

By B. Maron, L. Yeates, C. Semsarian. 2011

101 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. B. Maron
2. Steve R. Ommen
3. M. Maron
4. P. Spirito
5. C. Semsarian
6. Iacopo Olivotto
7. J. Udelson
8. Mark S. Link

Citations in the corpus

• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011, background): “(13) Assessment of clinical course in pts with a known”
• Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. (2014, background): “Relatives identified with pathogenic mutations but without evidence of the disease phenotype comprise a newHCM subgroup, designated as genotype positive-phenotype negative (24,40,51,52) (Central Illustration).”